Citigroup Forecasts Strong Price Appreciation for Healthcare Realty Trust (NYSE:HR) Stock

Healthcare Realty Trust (NYSE:HR) had its price target upped by Citigroup from $19.00 to $21.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. Citigroup’s price target would indicate a potential upside of 4.27% from the company’s current price.

Other analysts also recently issued research reports about the stock. Weiss Ratings downgraded shares of Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a report on Monday. UBS Group began coverage on shares of Healthcare Realty Trust in a report on Monday, April 20th. They issued a “neutral” rating and a $18.00 target price for the company. Wall Street Zen upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. Finally, Cantor Fitzgerald increased their target price on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Three investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $19.75.

Healthcare Realty Trust Stock Up 0.8%

Shares of NYSE HR opened at $20.14 on Thursday. The firm has a market cap of $7.03 billion, a PE ratio of -34.72 and a beta of 0.97. Healthcare Realty Trust has a 12-month low of $14.09 and a 12-month high of $20.46. The company’s fifty day simple moving average is $18.11 and its 200 day simple moving average is $17.73.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.02. The business had revenue of $275.28 million for the quarter, compared to analyst estimates of $283.01 million. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. Healthcare Realty Trust’s revenue was down 7.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.39 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. On average, equities analysts predict that Healthcare Realty Trust will post 1.61 earnings per share for the current year.

Insider Transactions at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The stock was acquired at an average price of $18.09 per share, for a total transaction of $180,900.00. Following the completion of the acquisition, the director owned 85,520 shares of the company’s stock, valued at approximately $1,547,056.80. This represents a 13.24% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.56% of the company’s stock.

Institutional Trading of Healthcare Realty Trust

A number of large investors have recently added to or reduced their stakes in HR. Dynamic Technology Lab Private Ltd purchased a new stake in Healthcare Realty Trust during the first quarter worth about $205,000. Empowered Funds LLC purchased a new stake in Healthcare Realty Trust during the first quarter worth about $202,000. Invesco Ltd. increased its holdings in Healthcare Realty Trust by 48.9% during the second quarter. Invesco Ltd. now owns 2,307,109 shares of the real estate investment trust’s stock worth $36,591,000 after buying an additional 757,542 shares during the last quarter. First Trust Advisors LP increased its holdings in Healthcare Realty Trust by 314.1% during the second quarter. First Trust Advisors LP now owns 223,125 shares of the real estate investment trust’s stock worth $3,539,000 after buying an additional 169,248 shares during the last quarter. Finally, Amundi increased its holdings in Healthcare Realty Trust by 154.0% during the second quarter. Amundi now owns 519,816 shares of the real estate investment trust’s stock worth $8,343,000 after buying an additional 315,179 shares during the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.